Cogent Biosciences, Inc. COGT Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s operating lease liabilities (current)?
- Cogent Biosciences, Inc. (COGT) reported operating lease liabilities (current) of $1.38M in Q1 2026.
- How has Cogent Biosciences, Inc.'s operating lease liabilities (current) changed year-over-year?
- Cogent Biosciences, Inc.'s operating lease liabilities (current) decreased by 14.2% year-over-year, from $1.61M to $1.38M.
- What is the long-term trend for Cogent Biosciences, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s operating lease liabilities (current) has grown at a -5.5% compound annual growth rate (CAGR), from $2.05M to $1.55M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.